Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

The Washington University

Status: Completed

Conditions: Chemotherapy; Adjuvant; Lung; Cancers

Study type: Observational

Funder types: Other

Identifiers

NCT00484016

06-0155

Details and patient eligibility

About

There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.

Full description

We propose to retrospectively examine the Washington University School of Medicine experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will retrospectively analyze the survival and outcomes in the lung cancer patients receiving adjuvant chemotherapy following surgical resection.

Enrollment: 45 patients

Sex: All

Ages: 18 to 88 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients that received adjuvant chemotherapy
• 18-88 years

Exclusion criteria

• Any patients that have not received adjuvant chemotherapy
• Patients under 18 or over 88